Form 4 for CYTK CYTOKINETICS INC
Accepted 2024-07-31 00:00:00 ET · period of report 2024-07-30 · accession 0001127602-24-021230 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-07-31 | 2024-07-30 | CYTK | Blum Robert I | Pres, CEO, Dir | M - OptEx | $6.67 | +11.5K | 410.9K | +3% | +$76.7K |
| D | 2024-07-31 | 2024-07-30 | CYTK | Blum Robert I | Pres, CEO, Dir | S - Sale+OE | $59.49 | -11.5K | 399.4K | -3% | -$684.1K |
| D | 2024-07-31 | 2024-07-30 | CYTK | Blum Robert I | Pres, CEO, Dir | M - OptEx | $0.00 | -11.5K | 101.2K | -10% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-07-30 | M | A | 11,500 | $6.67 | 410,912 | D | — | — | |
| 2 | Common | Common Stock | 2024-07-30 | S | D | 11,500 | $59.49 | 399,412 | D | — | — | |
| 3 | Derivative | Non-Qualified Stock Option (Right to Buy) | 2024-07-30 | M | D | 11,500 | $0.00 | 101,227 | D | $6.67 · 2016-03-23 to 2026-02-23 | 11,500 Common Stock |